Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 500 results found. Search for [ corona vaccine ]

Results 100 to 120 of 500
BusinessToday.In
October 14, 2020
India Stock Market Highlights Today: Tata Steel, Bharti Airtel, HCL Tech, Asian Paints and Bajaj Auto were among the top laggards today. On the other hand, ONGC, followed by NTPC, PowerGrid, UltraTech Cement, ITC, HDFC Bank, ICICI Bank and HDFC were among the top gainers.


BusinessToday.In
October 12, 2020
Coronavirus vaccine: There are four US-based companies whose vaccine candidates have moved into the crucial phase-3 development phase. This includes--Pfizer, Moderna, Johnson & Johnson, and Novavax


BusinessToday.In
October 11, 2020
Coronavirus update: The Health Ministry said that five states have the maximum caseload in the country -- Maharashtra, Karnataka, Kerala, Andhra Pradesh and Tamil Nadu


Associated Press
October 10, 2020
Coronavirus pandemic: Record high daily infections in several eastern European countries and sharp rebounds in the hard-hit west have made clear that Europe never really crushed the COVID-19 curve as hoped


BusinessToday.In
October 10, 2020
China was the first to report the outbreak, identified the pathogen and shared the genome sequence with the world, said Chinese Foreign Ministry spokesperson


Joe C Mathew
October 9, 2020
At least 38 COVID-19 applications filed by Indian innovators are pending before Indian Patent Office since the outbreak of the pandemic in the country


BusinessToday.In
New Delhi, October 9, 2020
India's drug regulator has declined a proposal from Hyderabad-based Dr Reddy's Laboratories Ltd to carry out a large study in the country to evaluate Russia's Sputnik-V coronavirus vaccine. The recommendations by an expert panel of the Central Drugs Standard Control Organisation (CDSCO) noted that safety and immunogenicity data from early-stage studies being conducted overseas is small, with no inputs available on Indian participants. Watch the video for more.Also Read: COVID-19 vaccine: Dr Reddy's asked to resubmit application for conducting trials of Sputnik V


BusinessToday.In
October 9, 2020
Bharat Biotech vaccine: The subject expert committee that discussed the matter in a meeting on October 5 has asked the company to resubmit the protocol and clarify the definition of asymptomatic


BusinessToday.In
October 8, 2020
Coronavirus vaccine update: The CDSCO panel said that safety and immunogenicity data from early-stage trials of the Russian vaccine Sputnik V that were conducted overseas had a small number of participants


BusinessToday.In
October 6, 2020
One of the causes attributed to the falling fresh positive cases is a natural fall in testing rates. Another reason is that the share of the Rapid Antigen Test vs the 'gold standard' PCR test has been rising


BusinessToday.In
New Delhi, October 5, 2020
In her keynote address at Business Today's Most Powerful Women event, Biocon Executive Chairperson, Kiran Mazumdar-Shaw, stressed on the need for very robust planning for vaccination of Indians by the government. This would require a very sophisticated technology platform to track the supply chain, maintain the cold supply chain in both rural and urban India and ensure availability of vaccines to more than a billion people. For the vaccination database, India could depend on Aadhaar to identify and trace people, she suggested.


PTI
October 4, 2020
Health Minister Harsh Vardhan said a high-level expert group is going into all the aspects of vaccines and the health ministry is preparing a format in which states will submit lists of priority population groups


BusinessToday.In
October 4, 2020
COVID-19 vaccine update: The Centre is deliberating allowing companies to secure vaccine doses directly and early on to ensure that there is no disruption of key economic activities


BusinessToday.In
October 3, 2020
COVID-19 vaccine: A principal investigator from a trial site in Maharashtra said that they are expecting to finish enrolling the participants within the next two months after which they will be monitored for the vaccine's efficacy


BusinessToday.In
New Delhi, October 1, 2020
The suspension on commercial international passenger flight services to or from India has been extended till October 31; The fifth phase of the opening up of the economy, that is Unlock 5.0, is set to begin from October 1; The chief executive of GlaxoSmithKline, the world's largest maker of vaccines, said she was optimistic the industry would be able to make an immunisation against COVID-19 widely available next year. Watch this and more on News Blast.Also Read: SC orders full refund for cancelled flight tickets during lockdown


BusinessToday.In
October 1, 2020
Coronavirus vaccine update: In India, there are three COVID-19 vaccines under human trials--Bharat Biotech's COVAXIN, Oxford's COVDSHIELD, and Zydus Cadila's ZyCoV-D. Serum Institute has already begun a phase-3 trial of Oxford vaccine candidates at 17 sites


Joe C Mathew
September 30, 2020
They state that access to means to fight COVID-19 on a global scale requires financial resources, assets, infrastructure, and jurisdictional support and collaboration beyond the capacity or role of each one of them


BusinessToday.In
New Delhi, September 28, 2020
The government is aiming to implement all the four labour codes in one go by December this year and complete the final stretch of labour sector reforms; With total cases standing at 32.4 million or 0.4 per cent of the world's population, every 250th person on the Earth is now infected with coronavirus; A day after Prime Minister Narendra Modi, in his address at the UN General Assembly, assured the world that India's vaccine production and delivery capacity will be used to help humanity in the COVID-19 crisis, world's largest vaccine maker Serum Institute of India (SII) Chief Executive Officer (CEO) Adar Poonawalla said SII also shares and applauds his vision. Watch this and more on News Blast.Also Read: SBI announces special benefits on home, auto, gold, personal loans


BusinessToday.In
September 27, 2020
Coronavirus in India: The country's recovery rate has improved to 82.46 per cent now and active cases stand at 15.96 per cent. The death rate in India is the lowest in the world at 1.58 per cent


BusinessToday.In
New Delhi, September 26, 2020
The CAG has found that the Union government in the very first two years of the GST implementation wrongly retained Rs 47,272 crore of GST compensation cess that was meant to be used specifically to compensate states for loss of revenue; British telecommunications company Vodafone has won arbitration against India over the retrospective tax demand of Rs 20,000 crore; Medical journal The Lancet, on Friday, said that the government was putting 'too positive spin' on the COVID-19 situation in India, calling on the country's leaders not to give false optimism to people. Watch this and more on News blast.Also Read: COVID-19 pandemic: Global death toll to reach 20 lakh before vaccine is widely used, says WHO


PAGES 6 OF 25  678910